alexa [Pregnancy-related hypertension: a cardiovascular risk situation].
Cardiology

Cardiology

Journal of Hypertension: Open Access

Author(s): MounierVehier C, Delsart P

Abstract Share this page

Abstract Pregnancy-related hypertension is defined by systolic blood pressure > or = 140 mmHg and/or diastolic blood pressure > or = 90 mmHg at any term. It is more appropriate to talk about "hypertensive pregnancy syndromes", for the clinical aspects can be very heterogeneous. This disease is still common and affects approximately 10 to 15\% of pregnancies. It essentially involves pathological placentation. When the maternal endothelium tolerates the trophoblast, the pregnancy is normal. Two elements play pivotal roles in the genesis of preeclampsia: defective placentation around 16 weeks of gestation and abnormal maternal response to placentation. Hypertension is difficult to diagnose during pregnancy because pregnant women are very subject to white coat hypertension. Self-monitoring and ambulatory monitoring of blood pressure are especially useful in this situation. Insofar as possible, it is important to distinguish preexisting hypertension, which preceded pregnancy, simple pregnancy-related hypertension, and more complicated forms, for their management differs. Treatment to lower blood pressure is aimed solely at preventing maternal complications of hypertension; lt has no effect on the course of the pregnancy and is sometimes even harmful for fetal growth. Except in cases of preeclampsia, it is not urgent to begin such treatment during pregnancy. If required, blood pressure should be reduced very progressively to maintain placental perfusion while slowly reaching a target value between 120/80 and 140/90 mmHg. Platelet aggregation inhibitors are the only effective preventive treatment for placental ischemia. They are reserved for at-risk pregnancies after 16 weeks of gestation, at a dose of 100mg/day. Short-term risks are associated especially with the complicated forms of hypertension. In the long term, preeclampsia is a marker of cardiovascular risk, for these women are at risk of developing chronic hypertension or having a cardiovascular accident in later years. Pregnancy is currently considered a situation that can reveal the likelihood of developing the metabolic syndrome and its cardiovascular complications. This article was published in Presse Med and referenced in Journal of Hypertension: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • International Conference on Hypertension
    October 30-31, 2017 Atlanta USA
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords